Breaking News
Sort by:
Top Post
Taysha Gene Therapies Announces First Patient Dosed with TSHA-102 in the REVEAL Phase 1/2 Trial for the Treatment of Rett Syndrome
Taysha Gene Therapies, a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene […]
Genethon Launches Pivotal Clinical Trial of Gene Therapy for Crigler-Najjar Syndrome, a Rare Liver Disease
Genethon, a unique non-profit gene therapy R&D organization founded by the French Muscular Dystrophy Association […]
Huma to Provide Best-in-class Digital Clinical Trials Solutions Through Landmark Acquisition of Alcedis
Huma Therapeutics, a leading global digital health company, today announced that it has acquired Alcedis […]
Phio Pharmaceuticals Announces Regulatory Clearance of Clinical Trial to Treat Solid Tumors
Phio Pharmaceuticals has announced their clinical development partner, AgonOx, has received confirmation from the FDA […]
New Partnership to Boost Research into Vaccines for Cancer
Trials into vaccines for cancer and wider diseases will accelerate after the government reached a […]
Sustained Therapeutics Advancing Clinical Trial for Novel Drug Delivery Platform
A Vancouver-based therapeutics company, Sustained Therapeutics, has received regulatory approval to begin the second Phase […]
OnQuality Pharmaceuticals Expands Part 2 of the NOVA-II Phase 2 Clinical Trial to China and India
OnQuality Pharmaceuticals, a targeted oncology supportive therapy company developing innovative medications to address the quality […]
Tempero Bio has Received FDA Clearance to Advance Clinical Development of TMP-301 for Treatment of Alcohol and Substance Use Disorders
Sosei Group Corporation, the world leader in G protein-coupled receptor (GPCR) focused structure-based drug design […]
Orano Med Starts Phase I Trial With Alpha Radioligand Therapy 212Pb-GRPR in Patients With Solid Tumors
Orano Med, a clinical stage radiopharmaceutical company, has announced that the first patient has been […]
Mission Bio and Abiosciences Partner to Co-develop Bioinformatics for Clinical Research Applications in China
Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, and Abiosciences, the single-cell […]
U.S. FDA Grants Breakthrough Designation for Blood Test to Help Diagnose Inaccessible Brain Tumors
Datar Cancer Genetics has announced that the US Food and Drug Administration (FDA) has granted […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more